Table 7.
CD3+ T-cells/μL | Pre-exercise | Post-exercise | 30-min post-exercise | %Δ pre- to post-exercise | Effect of time |
---|---|---|---|---|---|
Total | 1150 ± 483 | 1714 ± 740b | 1113 ± 616d | 50 ± 23 | F(2,14) = 19.22, p < 0.001, ηp2 = 0.76 |
CD8+ | 372 ± 243 | 654 ± 474a | 354 ± 268c | 76 ± 40 | F(1.09,7.65) = 10.24, p = 0.012, ηp2 = 0.59 |
CD8+CD28+CD57− | 116 ± 63 | 155 ± 89a | 125 ± 85 | 33 ± 28 | F(2,14) = 7.32, p = 0.007, ηp2 = 0.51 |
CD8+CD28−CD57+ | 155 ± 164 | 362 ± 373 | 126 ± 154 | 138 ± 40 | F(1.02,7.15) = 7.04, p = 0.032, ηp2 = 0.50 |
CD8+PD-1+ | 85 ± 48 | 138 ± 89a | 87 ± 61 | 62 ± 38 | F(2,14) = 9.08, p = 0.003, ηp2 = 0.57 |
CD8+CTLA-4+ | 178 ± 111 | 314 ± 192a | 155 ± 122c | 84 ± 53 | F(1.10,7.70) = 16.29, p = 0.004, ηp2 = 0.70 |
CD4+ | 729 ± 318 | 972 ± 430a | 717 ± 401c | 33 ± 20 | F(2,14) = 12.92, p < 0.001, ηp2 = 0.65 |
CD4+CD28+CD57− | 447 ± 226 | 638 ± 318 | 425 ± 285 | 59 ± 89 | F(2,14) = 5.75, p = 0.015, ηp2 = 0.45 |
CD4+CD28−CD57+ | 67 ± 138 | 54 ± 83 | 25 ± 34 | 75 ± 80 | F(2,14) = 0.61, p = 0.56, ηp2 = 0.08 |
CD4+PD-1+ | 170 ± 106 | 211 ± 124a | 146 ± 115 | 30 ± 30 | F(2,14) = 4.10, p = 0.040, ηp2 = 0.37 |
CD4+CTLA-4+ | 242 ± 159 | 293 ± 227 | 188 ± 118 | 16 ± 33 | F(2,14) = 3.57, p = 0.056, ηp2 = 0.34 |
ANOVA, analysis of variance; PD-1, programmed cell death protein-1; CTLA-4, cytotoxic T-lymphocyte associated protein-4.
indicates a significant difference from pre-exercise at p < 0.05.
indicates a significant difference from pre-exercise at p < 0.01.
indicates a significant difference from post-exercise at p < 0.05.
indicates a significant difference from post-exercise at p < 0.01.